{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:58:53Z","timestamp":1792191533259,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pathol.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T10:27:43Z","timestamp":1461925663000},"page":"336-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Loss of expression of BAP1 is very rare in non-small cell lung carcinoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Juliana","family":"Andrici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Parkhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Wardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Verdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Sioson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clarkson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Farzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Toon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.03.005_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2016.03.005_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2016.03.005_bib3","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.12-2345","article-title":"Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Alberg","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pathol.2016.03.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737140.2014.863713","article-title":"Family history and the risk of cancer: genetic factors influencing multiple cancer sites","volume":"14","author":"Turati","year":"2014","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.pathol.2016.03.005_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10552-010-9537-2","article-title":"Family history and lung cancer risk: international multicentre case\u2013control study in Eastern and Central Europe and meta-analyses","volume":"21","author":"Lissowska","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.pathol.2016.03.005_bib6","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ejca.2012.01.038","article-title":"Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium","volume":"48","author":"Cot\u00e9","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pathol.2016.03.005_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/mutage\/ger002","article-title":"The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case\u2013control studies","volume":"26","author":"Chen","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.pathol.2016.03.005_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00063198-199807000-00002","article-title":"Epidemiology of lung cancer","volume":"4","author":"Osann","year":"1998","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.pathol.2016.03.005_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.03.005_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/CMO.S15239","article-title":"The importance of multidisciplinary approach in early detection of BAP1 tumor predisposition syndrome: clinical management and risk assessment","volume":"8","author":"Battaglia","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.pathol.2016.03.005_bib11","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.03.005_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2016.03.005_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","article-title":"Loss of expression of BAP1 predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.03.005_bib14","doi-asserted-by":"crossref","first-page":"e2491","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.pathol.2016.03.005_bib15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-on","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1200\/JCO.2012.45.2003","article-title":"Molecular genetics of clear-cell renal cell carcinoma","volume":"32","author":"Brugarolas","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.03.005_bib17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of\u00a0BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.03.005_bib18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynaecological serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Andrici","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2016.03.005_bib20","doi-asserted-by":"crossref","first-page":"e0150338","DOI":"10.1371\/journal.pone.0150338","article-title":"Loss of BAP1 expression is very rare in pancreatic ductal adenocarcinoma","volume":"11","author":"Tayao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2016.03.005_bib21","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/sj.onc.1205835","article-title":"Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers","volume":"21","author":"Zabarovsky","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2016.03.005_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bfgp\/elm007","article-title":"Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease","volume":"6","author":"Angeloni","year":"2007","journal-title":"Brief Funct Genomic Proteomic"},{"key":"10.1016\/j.pathol.2016.03.005_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-physiol-021014-072018","article-title":"Unmasking the lung cancer epigenome","volume":"77","author":"Belinsky","year":"2015","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.pathol.2016.03.005_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lungcan.2006.12.010","article-title":"Chromosomal aberrations and gene expression profiles in non-small cell lung cancer","volume":"56","author":"Dehan","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pathol.2016.03.005_bib25","first-page":"6116","article-title":"The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium","volume":"60","author":"Lerman","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.03.005_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas","volume":"88","author":"de la Fouchardi\u00e8re","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib28","doi-asserted-by":"crossref","first-page":"e72144","DOI":"10.1371\/journal.pone.0072144","article-title":"A\u00a0BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers","volume":"8","author":"Aoude","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2016.03.005_bib29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/PAI.0000000000000025","article-title":"ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma","volume":"23","author":"Houang","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2016.03.005_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/PAT.0b013e32836532ae","article-title":"The International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma","volume":"45","author":"Westaway","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.03.005_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PAT.0000000000000141","article-title":"EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer","volume":"46","author":"Houang","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.03.005_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAT.0000000000000114","article-title":"Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer","volume":"46","author":"Houang","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.03.005_bib34","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.pathol.2016.03.005_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1513\/pats.201107-042ST","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary","volume":"8","author":"Travis","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pathol.2016.03.005_bib36","series-title":"AJCC Cancer Staging Manual","author":"Rusch","year":"2009"},{"key":"10.1016\/j.pathol.2016.03.005_bib37","unstructured":"COSMIC: Catalogue of Somatic Mutations in Cancer. Cited 20 Jan 2016. http:\/\/cancer.sanger.ac.uk\/cosmic\/gene\/analysis?ln=BAP1."},{"key":"10.1016\/j.pathol.2016.03.005_bib38","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.03.005_bib39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A\u00a0cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pathol.2016.03.005_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A\u00a0distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.03.005_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.03.005_bib43","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2016.03.005_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.03.005_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2016.03.005_bib46","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.03.005_bib47","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516339630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T01:20:44Z","timestamp":1536801644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516339630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0031302516339630"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.005","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of expression of BAP1 is very rare in non-small cell lung carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}